Robotic Stereotactic Body Radiotherapy for Localized Prostate Cancer: Final Analysis of the German Hypostat Trial
David Krug, Detlef Imhoff, Alfred Haidenberger, Nicole Heßler, Jane Schäfer, Stefan Huttenlocher, Georgios Chatzikonstantinou, Christoph Fürweger, Ulla Ramm, Inke R König, Felix Chun, Michael Staehler, Claus Rödel, Alexander Muacevic, Reinhard Vonthein, Jürgen Dunst, Oliver Blanck | Strahlenther Onkol | 2023
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]
Efficacy and toxicity of chemoradiation in patients with anal cancer–a retrospective analysis
Koerber SA, Slynko A, Haefner MF, Krug D, Schoneweg C, Kessel K, Kopp-Schneider A, Herfarth K, Debus J, Sterzing F | Radiat Oncol | 2014
Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer
Joseph K, Vos LJ, Warkentin H, Paulson K, Polkosnik LA, Usmani N, Tankel K, Severin D, Nijjar T, Schiller D, Wong C, Ghosh S, Mulder K, Field C | Radiother Oncol | 2016
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients
De Bari B, Lestrade L, Franzetti-Pellanda A, Jumeau R, Biggiogero M, Kountouri M, Matzinger O, Miralbell R, Bourhis J, Ozsahin M, Zilli T | J Cancer Res Clin Oncol | 2018
Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy
Klausner G, Blais E, Jumeau R, Biau J, de Meric de Bellefon M, Ozsahin M, Zilli T, Miralbell R, Thariat J, Troussier I | Med Oncol | 2018
A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma
Huang CM, Huang MY, Tsai HL, Huang CW, Ma CJ, Lin CH, Huang CJ, Wang JY | J Radiat Res | 2017
Concomitant dose escalation with image-guided Tomotherapy in locally advanced mid-low rectal cancer: a single-center study
Zhao J, Liu X, Wang W, Hu K, Zhang F, Hou X, Meng Q | Cancer Manag Res | 2019
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series
De Bari B, Franzetti-Pellanda A, Saidi A, Biggiogero M, Hahnloser D, Montemurro M, Bourhis J, Zeverino M, Ozsahin M | J Cancer Res Clin Oncol | 2019
A comparison of dosimetric and clinical parameters between different IMRT boost techniques in preoperative rectal cancer
Karaca S, Aysenur Arli Karacam K | J BUON | 2021
A comparative planning study of step-and-shoot IMRT versus helical tomotherapy for whole-pelvis irradiation in cervical cancer
Chitapanarux I, Tharavichitkul E, Nobnop W, Wanwilairat S, Vongtama R, Traisathit P | J Radiat Res | 2015
Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report
Cordoba A, Nickers P, Tresch E, Castelain B, Leblanc E, Narducci F, Le Tinier F, Lesoin A, Lacornerie T, Lartigau E | Rep Pract Oncol Radiother | 2015
Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study
Arians N, Kieser M, Benner L, Rochet N, Schröder L, Katayama S, Herfarth K, Schubert K, Schneeweiss A, Sohn C, Lindel K, Debus J | Radiat Oncol | 2019
Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer
Kim S, Lee S, Hong JH, Park YJ, Song JY, Lee JK, Lee NW | J Gynecol Oncol | 2020
Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer
Mukai Y, Minagawa Y, Inoue H, Sato A, Matsui K, Fukuda T, Onuma K, Hongo H, Shirata R, Nagata H, Hashimoto H, Inoue T, Hata M, Omura M | In Vivo | 2020
Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity
Zhang G, He F, Miao L, Wu H, Zhang Y, Fu C | Jpn J Clin Oncol | 2021
Efficacy of helical tomotherapy combined with CT-guided three-dimensional intracavitary brachytherapy in treatment of locally advanced cervical cancer
Ye X, Ye P, Zheng Y, Xia W | J BUON | 2021
The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy
Cheng YK, Kuo SH, Yen HH, Wu JH, Chen YC, and Huang MY | Radiat Oncol | 2022
Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancer – PubMed (nih.gov)
Li D, Wang D, Feng S, Chen Q, Sheng X, Jia J, Yan X, Zhu J, and Yin Y | Oncol Lett | 2022
High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
Tomita N, Soga N, Ogura Y, Hayashi N, Kageyama T, Ito M, Koide Y, Yoshida M, Kimura K, Makita C, Tachibana H, Kodaira T | J Cancer Res Clin Oncol | 2016
